Jump to Main Content
Cardiac biomarkers in cats
- Borgeat, K., Connolly, D.J., Luis Fuentes, V.
- Journal of veterinary cardiology 2015 v.17 pp. S74
- biomarkers, cardiomyopathy, cats, distress, natriuretic peptides, troponin I, urine
- Cardiac biomarkers have been used in cats as part of the clinical assessment of heart disease for over a decade. They are widely available to practitioners through commercial reference laboratories. The evidence base for the use of cardiac biomarkers (primarily N-terminal pro-B type natriuretic peptide and cardiac troponin I) in cats is comprehensively reviewed in this article, focusing on each of six specific areas: distinguishing cardiac from non-cardiac causes of respiratory distress; measurement of cardiac biomarkers in urine and pleural fluid; identification of occult cardiomyopathy; effects of systemic disease on circulating concentrations of cardiac biomarkers; point-of-care biomarker testing, and the possible prognostic utility of cardiac biomarker measurement.